SCHEMBL30262008

CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O

nearest known ligand 0.58

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	5/20	0.58

▸	ECE1	P42892	1/20	0.58

▸	MUS81	Q96NY9	1/20	0.58

▸	PTH1R	Q03431	4/20	0.57

▸	IL23R	Q5VWK5	6/20	0.56

▸	MAGI3	Q5TCQ9	1/20	0.56

▸	KISS1R	Q969F8	2/20	0.55

▸	GCGR	P47871	1/20	0.55

▸	GIPR	P48546	1/20	0.55

▸	KEAP1	Q14145	1/20	0.54

▸	RXFP1	Q9HBX9	1/20	0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30262238	0.90	IL23R (0.60)	GLP1RECE1MUS81PTH1RIL23R
SCHEMBL31275967	0.88	RXFP1 (0.65)	GLP1RECE1MUS81IL23RRXFP1
SCHEMBL29880080	0.88	PTH1R (0.64)	GLP1RECE1MUS81PTH1RGCGR
SCHEMBL30261961	0.87	PTH1R (0.67)	GLP1RECE1MUS81PTH1RGCGR
SCHEMBL30130545	0.87	MAGI3 (0.58)	GLP1RECE1MUS81PTH1RIL23R
SCHEMBL30130570	0.87	MAGI3 (0.58)	GLP1RECE1MUS81PTH1RIL23R
SCHEMBL30498854	0.87	GLP1R (0.64)	GLP1RECE1MUS81PTH1RIL23R
SCHEMBL29396018	0.86	IL23R (0.61)	PTH1RIL23RKEAP1
SCHEMBL30262062	0.86	KISS1R (0.67)	IL23RKISS1R
SCHEMBL30883240	0.86	GLP1R (0.71)	GLP1RECE1MUS81IL23R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20230040544-A1	COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC)	SAREPTA THERAPEUTICS, INC.	2023-02-09	—	—	US	disclosed